0.30 USD
▲+0.00+0.34%
盘后 0.28 -6.44%
2026-08-03
市值
$7.79M
市盈率
—
EPS
-3.15
股息率
—
52 周区间
0.22 – 1.45
成交量
434.35K
Beta
0.61
目标价
6.70
52W 低 0.2252W 高 1.45
价格走势
公司简介
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine. It also develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is base...